{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:52:02Z","timestamp":1794243122755,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.amjmed.2025.05.042","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T10:39:24Z","timestamp":1748774364000},"page":"1418-1427.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of Cancer and Anti-Synthetase Syndrome: A Retrospective Multicenter Study"],"prefix":"10.1016","volume":"138","author":[{"given":"Laura","family":"Bucy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Devilliers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Manneville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Bonnotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Ribeiro","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Guillaumot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bonniaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Francis","family":"Maillefert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Servettaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Campagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Magy-Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Jaussaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4134-6086","authenticated-orcid":false,"given":"Thomas","family":"Moulinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjmed.2025.05.042_bib0001","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and prevalence of inflammatory myopathies: a systematic review","volume":"54","author":"Meyer","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.amjmed.2025.05.042_bib0002","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.amjmed.2025.05.042_bib0003","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjmed.2025.05.042_bib0004","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.amjmed.2025.05.042_bib0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.amjmed.2025.05.042_bib0006","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.amjmed.2025.05.042_bib0007","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1212\/WNL.61.3.288","article-title":"Unicorns, dragons, polymyositis, and other mythological beasts","volume":"61","author":"Amato","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2025.05.042_bib0008","first-page":"483","article-title":"Polymyositis","author":"Stertz","year":"1916","journal-title":"Berl Klin Wochenschr"},{"key":"10.1016\/j.amjmed.2025.05.042_bib0009","doi-asserted-by":"crossref","unstructured":"Wakata N, Kurihara T, Saito E, Kinoshita M. Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol. Published online 2002;41(11):729-734.","DOI":"10.1046\/j.1365-4362.2002.01648.x"},{"issue":"4","key":"10.1016\/j.amjmed.2025.05.042_bib0010","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","article-title":"Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study","volume":"144","author":"Chen","year":"2001","journal-title":"Br J Dermatol"},{"issue":"9250","key":"10.1016\/j.amjmed.2025.05.042_bib0011","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.amjmed.2025.05.042_bib0012","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bjd.12564","article-title":"Meta-analysis of the association of dermatomyositis and polymyositis with cancer","volume":"169","author":"Wang","year":"2013","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.amjmed.2025.05.042_bib0013","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.amjmed.2025.05.042_bib0014","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.2005.040717","article-title":"Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.amjmed.2025.05.042_bib0015","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1093\/rheumatology\/keab166","article-title":"A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies","volume":"60","author":"Oldroyd","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.amjmed.2025.05.042_bib0016","article-title":"Malignancy in dermatomyositis: a mono-centric retrospective study of 134 patients in China and a potential predictive model","volume":"10","author":"Tang","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.amjmed.2025.05.042_bib0017","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1212\/NXI.0000000000000290","article-title":"Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy","volume":"3","author":"Kadoya","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"Pt 8","key":"10.1016\/j.amjmed.2025.05.042_bib0018","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/aww054","article-title":"High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody","volume":"139","author":"Allenbach","year":"2016","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.amjmed.2025.05.042_bib0019","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.amjmed.2025.05.042_bib0020","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.33403","article-title":"Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins","volume":"64","author":"Fujimoto","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.amjmed.2025.05.042_bib0021","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/RHU.0b013e31823b1878","article-title":"Antisynthetase syndrome and malignancy: our experience","volume":"17","author":"Casta\u00f1eda-Pomeda","year":"2011","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.amjmed.2025.05.042_bib0022","first-page":"169","article-title":"Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome","volume":"35","author":"Legault","year":"2008","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.amjmed.2025.05.042_bib0023","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/ar4332","article-title":"Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome","volume":"15","author":"Marie","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.amjmed.2025.05.042_bib0024","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","article-title":"Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity","volume":"12","author":"Hervier","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.amjmed.2025.05.042_bib0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41584-023-01045-w","article-title":"International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative","volume":"19","author":"Oldroyd","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.amjmed.2025.05.042_bib0026","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.amjmed.2025.05.042_bib0027","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"10.1016\/j.amjmed.2025.05.042_bib0028","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.amjmed.2025.05.042_bib0029","unstructured":"Institut National du Cancer, R\u00e9publique Fran\u00e7aise. Donn\u00e9es globales d\u2019\u00e9pid\u00e9miologie des cancers - Epid\u00e9miologie des cancers. Available at:https:\/\/www.e-cancer.fr\/Professionnels-de-sante\/Les-chiffres-du-cancer-en-France\/Epidemiologie-des-cancers\/Donnees-globales. Accessed August 4, 2024."},{"issue":"1","key":"10.1016\/j.amjmed.2025.05.042_bib0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2105\/AJPH.2012.300897","article-title":"Multivariate or multivariable regression?","volume":"103","author":"Hidalgo","year":"2013","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.amjmed.2025.05.042_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v070.i01","article-title":"missMDA: A Package for Handling Missing Values in Multivariate Data Analysis","volume":"70","author":"Josse","year":"2016","journal-title":"J Stat Softw"},{"key":"10.1016\/j.amjmed.2025.05.042_bib0032","doi-asserted-by":"crossref","unstructured":"Wickham H, Hester J, Bryan J. readr: Read Rectangular Text Data. Available at: https:\/\/CRAN.R-project.org\/package=readr. 2022. Accessed June 14, 2025.","DOI":"10.32614\/CRAN.package.meltr"},{"issue":"1","key":"10.1016\/j.amjmed.2025.05.042_bib0033","doi-asserted-by":"crossref","first-page":"570","DOI":"10.32614\/RJ-2021-053","article-title":"Reproducible summary tables with the gtsummary package","volume":"13","author":"Sjoberg","year":"2021","journal-title":"R J"},{"issue":"43","key":"10.1016\/j.amjmed.2025.05.042_bib0034","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"issue":"1","key":"10.1016\/j.amjmed.2025.05.042_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v025.i01","article-title":"FactoMineR: a package for multivariate analysis","volume":"25","author":"L\u00ea","year":"2008","journal-title":"J Stat Softw"},{"key":"10.1016\/j.amjmed.2025.05.042_bib0036","unstructured":"Vaissie P, Monge A, Husson F. Factoshiny: perform factorial analysis from \u201cFactoMineR\u201d with a shiny application. Available at: https:\/\/CRAN.R-project.org\/package=Factoshiny. 2021. Accessed June 14, 2025."},{"issue":"10","key":"10.1016\/j.amjmed.2025.05.042_bib0037","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","article-title":"Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome","volume":"11","author":"Marie","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.amjmed.2025.05.042_bib0038","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/RHU.0b013e31817d116f","article-title":"Malignancy in the setting of the anti-synthetase syndrome","volume":"14","author":"Rozelle","year":"2008","journal-title":"J Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.amjmed.2025.05.042_bib0039","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/RHU.0b013e3181b0e910","article-title":"Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience","volume":"15","author":"Mileti","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.amjmed.2025.05.042_bib0040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejim.2023.06.012","article-title":"Phenotypic profiles among 72 Caucasian and Afro-Caribbean patients with antisynthetase syndrome involving Anti-PL7 or Anti-PL12 autoantibodies","volume":"115","author":"Abel","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.amjmed.2025.05.042_bib0041","first-page":"190","article-title":"Clinical characterisation of a multicentre nationwide cohort of patients with antisynthetase syndrome","volume":"1","author":"Martins","year":"2022","journal-title":"ARP Rheumatol"},{"issue":"1","key":"10.1016\/j.amjmed.2025.05.042_bib0042","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","article-title":"The EuroMyositis registry: an international collaborative tool to facilitate myositis research","volume":"77","author":"Lilleker","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjmed.2025.05.042_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101392","article-title":"Aminoacyl-tRNA synthetases of the multi-tRNA synthetase complex and their role in tumorigenesis","volume":"19","author":"Khan","year":"2022","journal-title":"Transl Oncol"},{"issue":"11","key":"10.1016\/j.amjmed.2025.05.042_bib0044","first-page":"870","article-title":"Neoplastic fever: a neglected paraneoplastic syndrome","volume":"13","author":"Zell","year":"2005","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.amjmed.2025.05.042_bib0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.semarthrit.2016.03.011","article-title":"Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group","volume":"46","author":"Trallero-Aragu\u00e1s","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.amjmed.2025.05.042_bib0046","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/1756-185X.14046","article-title":"Risk factors for cancer-associated myositis:a large-scale multicenter cohort study","volume":"24","author":"Li","year":"2021","journal-title":"Int J Rheum Dis"},{"issue":"9","key":"10.1016\/j.amjmed.2025.05.042_bib0047","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s10067-015-3023-x","article-title":"Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD)","volume":"34","author":"Rojas-Serrano","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.amjmed.2025.05.042_bib0048","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13075-022-02786-x","article-title":"Assessing the diagnostic value of a potential screening tool for detecting early interstitial lung disease at the onset of inflammatory rheumatic diseases","volume":"24","author":"Hoffmann","year":"2022","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.amjmed.2025.05.042_bib0049","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","article-title":"Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody","volume":"41","author":"Marie","year":"2012","journal-title":"Semin Arthritis Rheum"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293432500347X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293432500347X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T08:16:03Z","timestamp":1758269763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293432500347X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S000293432500347X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2025.05.042","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Cancer and Anti-Synthetase Syndrome: A Retrospective Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2025.05.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}